Search

Integra LifeSciences Holdings Corp

Closed

SectorHealthcare

18.95 -0.05

Overview

Share price change

24h

Current

Min

18.52

Max

19.27

Key metrics

By Trading Economics

Income

-2.9M

-4.6M

Sales

-43M

392M

EPS

0.54

Profit margin

-1.178

Employees

4,427

EBITDA

-3.1M

63M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+9.42% upside

Dividends

By Acuity

Next Earnings

29 Jul 2026

Market Stats

By TradingEconomics

Market Cap

632M

1.5B

Previous open

19

Previous close

18.95

News Sentiment

By Acuity

24%

76%

45 / 340 Healthcare

Integra LifeSciences Holdings Corp Chart

Past performance is not a reliable indicator of future results.

Related News

21 Jul 2026, 18:46 UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

20 Jul 2026, 19:26 UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Peer Comparison

Price change

Integra LifeSciences Holdings Corp Forecast

Price Target

By TipRanks

9.42% upside

12 Months Forecast

Average 20.67 USD  9.42%

High 27 USD

Low 15 USD

Based on 8 Wall Street analysts offering 12 month price targets forIntegra LifeSciences Holdings Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

2

Buy

5

Hold

1

Sell

Sentiment

By Acuity

45 / 340 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat